Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lauer

Showing results (551-560 of 604) with videos related to

Pageof 61
Sort By:
Blood|May 4, 2007
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infectionJulian Schulze Zur Wiesch, Georg M Lauer, Joerg Timm, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cureFang Chen, Erick Giang, Padmaja Natarajan, et al.
Molecular Cell|June 27, 2025
An NADH-controlled gatekeeper of ATP synthaseFabian Schildhauer, Petra S J Ryl, Simon M Lauer, et al.
Nature Immunology|July 27, 2021
Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humansKathleen B Yates, Pierre Tonnerre, Genevieve E Martin, et al.
Plos One|June 7, 2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationJulia M Grottenthaler, Christoph R Werner, Martina Steurer, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeChristoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, et al.
Neuro-Oncology|September 15, 2023
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomasEliza M Lauer, Ella Riegler, Jurik A Mutter, et al.
Oncogene|May 26, 2026
An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samplesBenjamin Schoeps, Stefanie Estermann, Susanne Berchtold, et al.
Science (New York, N.Y.)|October 30, 2016
The epigenetic landscape of T cell exhaustionDebattama R Sen, James Kaminski, R Anthony Barnitz, et al.
Journal of Hepatology|June 18, 2022
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen<sup>+</sup> infectionRuben C Hoogeveen, Suzan Dijkstra, Lea M Bartsch, et al.
Pageof 61

Showing results (551-560 of 604) with videos related to

Sort By:
Pageof 61
Blood|May 4, 2007
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infectionJulian Schulze Zur Wiesch, Georg M Lauer, Joerg Timm, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cureFang Chen, Erick Giang, Padmaja Natarajan, et al.
Molecular Cell|June 27, 2025
An NADH-controlled gatekeeper of ATP synthaseFabian Schildhauer, Petra S J Ryl, Simon M Lauer, et al.
Nature Immunology|July 27, 2021
Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humansKathleen B Yates, Pierre Tonnerre, Genevieve E Martin, et al.
Plos One|June 7, 2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationJulia M Grottenthaler, Christoph R Werner, Martina Steurer, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeChristoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, et al.
Neuro-Oncology|September 15, 2023
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomasEliza M Lauer, Ella Riegler, Jurik A Mutter, et al.
Oncogene|May 26, 2026
An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samplesBenjamin Schoeps, Stefanie Estermann, Susanne Berchtold, et al.
Science (New York, N.Y.)|October 30, 2016
The epigenetic landscape of T cell exhaustionDebattama R Sen, James Kaminski, R Anthony Barnitz, et al.
Journal of Hepatology|June 18, 2022
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen<sup>+</sup> infectionRuben C Hoogeveen, Suzan Dijkstra, Lea M Bartsch, et al.
Pageof 61